TZOO
$23.84
(4.2%)
FLWS
$8.05
(-0.62%)
ACCO
$4.99
(-2.16%)
AUXXF
$0.1
(-9.52%)
ARLP
$26.62
(-2.42%)
ALVOF
$3.42
(-2.09%)
AUIAF
$0.38
(15.01%)
BSET
$14.15
(1.36%)
BXRX
$0
(0%)
BBGI
$7.76
(-0.26%)
BSGM
$0.91
(-2.17%)
BLBX
$3.27
(9.36%)
LUCK
$10.94
(-2.23%)
COCP
$1.83
(-3.17%)
CDRO
$6.86
(0.81%)
LODE
$0.39
(8.73%)
CMTL
$2.34
(-4.49%)
CXW
$18.43
(-1.76%)
LCE:CA
$0.26
(1.96%)
CMLS
$0.86
(-6.45%)
DEFN:CA
$0.18
(5.88%)
DTGI
$0.01
(12.36%)
DRCT
$1.16
(0.87%)
DLHC
$6.35
(0.32%)
SSP
$1.73
(-4.42%)
EGLE
$62.6
(0%)
ELMGF
$0.02
(7.04%)
UUUU
$5.19
(2.37%)
GAME
$0.89
(-0.38%)
EVC
$2.16
(-2.26%)
ESK:CA
$0.18
(-5.26%)
GMBL
$0.27
(-21.33%)
EDRY
$10.9
(-0.27%)
ESEA
$32.85
(0.74%)
GNK
$14.39
(-0.9%)
GEVO
$1.87
(-3.11%)
GRIN
$14.2
(0%)
GTN
$3.93
(-3.68%)
HHS
$5.41
(-0.73%)
INDO
$2.7
(-1.46%)
IPOOF
$1.18
(1.29%)
KNDI
$1.07
(-1.38%)
MSGM
$1.37
(2.34%)
PANL
$5.2
(-1.89%)
PXS
$3.79
(-1.56%)
QMCI
$0.18
(-0.06%)
SALM
$0.84
(1.57%)
SHIP
$6.66
(0.08%)
TSQ
$9
(-0.77%)
TZOO
$23.84
(4.2%)
FLWS
$8.05
(-0.62%)

2/7/2025

Alumis and ACELYRIN Announce Definitive Merger Agreement in All-Stock Transaction

Key Points:– Alumis and ACELYRIN have agreed to an all-stock merger, creating a well-capitalized biopharmaceutical company focused on advancing immunology treatments.– The combined company will have approximately $737 million in cash and securities, supporting multiple clinical trial readouts and operations into 2027.– Alumis will retain its name and leadership team, with an expanded board including […]

0
3 min read

  • Noble Capital Markets Research Morning Call

    Noble Capital Markets Research Morning Call

    Today’s Noble Capital Markets equity research reports, available with free...

    146 min read
  • January Jobs Report Shows Slower-Than-Expected Growth

    3 min read
  • [object Object]
  • TPG to Acquire Altus Power in $2.2 Billion Deal

    3 min read

News

2/7/2025

Release – ISG to Announce Fourth-Quarter Financial Results

2 min read

Release – ISG to Announce Fourth-Quarter Financial Results
2/7/2025

Release – Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

5 min read

Release – Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™
2/7/2025

Release – Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human

6 min read

Release – Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human
2/7/2025

Release – Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash

10 min read

Release – Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash

Video Content


  • Ranger Energy Services

    Ranger Energy Services

    Conference Presentation
    1/14/2025

  • P3 Health Partners

    P3 Health Partners

    Conference Presentation
    12/19/2024

  • Unicycive Therapeutics Inc.

    Unicycive Therapeutics Inc.

    Conference Presentation
    12/19/2024

  • Performant

    Performant

    Conference Presentation
    12/18/2024